|
CNTX
|
Context Therapeutics Inc.
|
US
|
NASDAQ
|
|
CORT
|
Corcept Therapeutics Incorporated
|
US
|
NASDAQ
|
|
CRNX
|
Crinetics Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
DXCM
|
DexCom, Inc.
|
US
|
NASDAQ
|
|
ENTX
|
Entera Bio Ltd.
|
US
|
NASDAQ
|
|
MDGL
|
Madrigal Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
MNKD
|
MannKind Corporation
|
US
|
NASDAQ
|
|
MYOV
|
Myovant Sciences Ltd.
|
US
|
NYSE
|
|
NMRD
|
Nemaura Medical Inc.
|
US
|
NASDAQ
|
|
NVO
|
Novo Nordisk A/S
|
US
|
NYSE
|
|
ORGS
|
Orgenesis Inc.
|
US
|
NASDAQ
|
|
ORMP
|
Oramed Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
PODD
|
Insulet Corporation
|
US
|
NASDAQ
|
|
PTN
|
Palatin Technologies, Inc.
|
US
|
AMEX
|
|
RANI
|
Rani Therapeutics Holdings, Inc.
|
US
|
NASDAQ
|
|
TNDM
|
Tandem Diabetes Care, Inc.
|
US
|
NASDAQ
|
|
TXMD
|
TherapeuticsMD, Inc.
|
US
|
NASDAQ
|
|
ACR
|
Acrux Limited
|
AU
|
ASX
|
|
ANP
|
Antisense Therapeutics Limited
|
AU
|
ASX
|
|
IXC
|
Invex Therapeutics Ltd
|
AU
|
ASX
|